25 October 2021 - We make this version number 10.
The Department of Health has published a revised agenda for next month's PBAC meeting.
Version 9 states that the submission for cemiplimab (Libtayo) was withdrawn. Version 10 states that the submission has not been withdrawn but rather will be considered at a future PBAC meeting.